These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. The Beneficial Role Of Anti-Phospholipase A2 Receptor Auto-Antibodies And Rituximab In The Management Of Recurrent Primary Membranous Nephropathy After Kidney Transplantation. Anjum N; Nabi Z J Ayub Med Coll Abbottabad; 2021; 33(2):315-318. PubMed ID: 34137554 [TBL] [Abstract][Full Text] [Related]
9. Recurrent membranous nephropathy in an allograft caused by IgG3κ targeting the PLA2 receptor. Debiec H; Hanoy M; Francois A; Guerrot D; Ferlicot S; Johanet C; Aucouturier P; Godin M; Ronco P J Am Soc Nephrol; 2012 Dec; 23(12):1949-54. PubMed ID: 23123401 [TBL] [Abstract][Full Text] [Related]
10. [Membranous nephropathy: New insights in therapeutic approach]. Dahan K Nephrol Ther; 2017 Apr; 13 Suppl 1():S83-S87. PubMed ID: 28577748 [TBL] [Abstract][Full Text] [Related]
11. Clinical usefulness of autoantibodies to M-type phospholipase A2 receptor (PLA2R) for monitoring disease activity in idiopathic membranous nephropathy (IMN). Radice A; Trezzi B; Maggiore U; Pregnolato F; Stellato T; Napodano P; Rolla D; Pesce G; D'Amico M; Santoro D; Londrino F; Ravera F; Ortisi G; Sinico RA Autoimmun Rev; 2016 Feb; 15(2):146-54. PubMed ID: 26527329 [TBL] [Abstract][Full Text] [Related]
12. Anti-phospholipase A2 Receptor Antibody and Immunosuppression in Membranous Nephropathy: More Evidence for Pathogenicity of Anti-phospholipase A2 Receptor Autoantibodies. Brenchley PE J Am Soc Nephrol; 2015 Oct; 26(10):2308-11. PubMed ID: 25804283 [No Abstract] [Full Text] [Related]
13. Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy. Hoxha E; Kneißler U; Stege G; Zahner G; Thiele I; Panzer U; Harendza S; Helmchen UM; Stahl RA Kidney Int; 2012 Oct; 82(7):797-804. PubMed ID: 22673885 [TBL] [Abstract][Full Text] [Related]
14. Pregnancy in a Patient With Primary Membranous Nephropathy and Circulating Anti-PLA2R Antibodies: A Case Report. Al-Rabadi L; Ayalon R; Bonegio RG; Ballard JE; Fujii AM; Henderson JM; Salant DJ; Beck LH Am J Kidney Dis; 2016 May; 67(5):775-8. PubMed ID: 26744127 [TBL] [Abstract][Full Text] [Related]
16. Anti-neutrophil cytoplasmic antibody-associated glomerulonephritis with detection of myeloperoxidase and phospholipase A Tominaga K; Uchida T; Imakiire T; Itoh K; Shimazaki H; Nakanishi K; Kumagai H; Oshima N BMC Nephrol; 2018 May; 19(1):120. PubMed ID: 29792176 [TBL] [Abstract][Full Text] [Related]
17. The relationship of anti-phospholipase A2 receptor antibody and C5a complement with disease activity and short-term outcome in idiopathic membranous nephropathy. Chi JN; Lai TS; Wu CF; Fu TY; Chou YH; Chiu YL; Lin WC; Chiang WC; Chen YM; Wu MS J Formos Med Assoc; 2019 May; 118(5):898-906. PubMed ID: 30639075 [TBL] [Abstract][Full Text] [Related]